INTRODUCTION
The genus Acinetobacter comprises a complex and heterogeneous group of bacteria, many of which are capable of causing a range of opportunistic infections in humans. Community acquired infections due to Acinetobacter are rare. The main pathogenic species is Acinetobacter baumannii complex, which constitutes a common cause of nosocomial infections, particularly in patients with underlying diseases and risk factors (e.g. prior broad-spectrum antibiotic therapy, malignancy, central venous catheter, mechanical ventilation). 1, 2 Acinetobacter species other than A. baumannii have rarely been reported to be associated with bloodstream infections. In this report we present a case of bacteremia caused by Acinetobacter junii in an immunocompetent adult.
CASE REPORT
A 45 year old male, normotensive, non-diabetic, chronic smoker was admitted in ward 6 of medical unit IV with complaints of fever and dry cough of ten days duration. The patient had been on phenytoin since 2 years for a seizure disorder due to AV malformation in the frontal lobe. At admission he was conscious, well oriented with a pulse rate of 88/min and BP 110/70 mmHg.
Lab investigations
His haemogram was as follows; Hb -11.7gm; WBC count 6500/µl; (neutrophils 65.6%, lymphocytes 16.4%); platelets 2 lacs. The liver and renal parameters were normal. He tested negative for Monteaux, Widal and Malarial parasite. X ray Chest showed right sub pleural fibrosis with right pleural thickening, Bronchoscopy showed no abnormalities and his sputum and BAL examination were negative for AFB.
Microbiological investigation
Three sets of blood cultures were drawn at 0, 24 and 48 hours from different venipuncture sites. After 24 hours of incubation, colonies were found on sheep blood agar and MacConkeys agar (Figure 1 ) which was 1.5-2 mm in diameter and non-lactose fermenting. On staining these isolates appeared as gram-negative cocco bacillary forms (Figure 2 ). Further identification and antibiotic sensitivity was done on VITEK 2 compact 60 Biomerieux, India Pvt., ltd. The isolate was identified as A. junii and it was sensitive to cefatizidime, cefaperazone and sulbactam, cefepime, aztreonam, doripenem, imipenem, meropenem, amikacin, gentamycin, ciprofloxacin, minocycline, tigicycline, trimethoprim & sulphamethoxazole but resistant to colistin. The patient was put on medication and there was complete resolution of his signs and symptoms. Repeat blood cultures were negative and the patient was discharged. A. junii (genomic species 5) is a rare human pathogen, being particularly associated with outbreaks of septicaemia in neonates and paediatric oncology patients. [3] [4] [5] Rare cases of meningitis, peritonitis, ocular infection and septicaemia in an adult oncology patient caused by A. junii have also been described. 4, [6] [7] [8] Relatively few infections caused by Acinetobacter spp. are community acquired, reported primarily from countries with tropical or subtropical climate, and mainly affected patients with some form of comorbidity or associated with heavy smoking and excess alcohol consumption. 6, 7 A. junii rarely causes infections in humans. 9 In larger analyses from Europe, strains of A. junii constitute 3.6-4.8% of all Acinetobacter isolates-12/331 and 9/186, respectively.
10,11 It mainly affects patients who have had prior antimicrobial therapy, invasive procedures, or malignancy. 9 Although A. junii is capable of causing serious infections, they are generally non-fatal because the micro-organism is commonly susceptible to antimicrobial agents. 3 The present case represents the first documented case of bacteremia by A. junii in an adult immunocompetent patient.
It should be noted that A. non-baumannii species, including A. junii, may cause bacteremia in an otherwise healthy patient. Special attention should be given to the correct identification of Acinetobacter non-baumannii species, which will contribute to a better understanding of the epidemiology and the real clinical impact of these species as a cause of infections in humans.
